The present invention, including the crystalline form, (8 S ,9 R )-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1 H -1,2,4-triazole -5-yl) -8,9-dihydro-2 H -pyrido[4,3,2- de ]phthalazine-3(7 H )-one tosylate salt forms, and methods for their preparation are provided. do. Further, (8 S ,9 R )-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1 H -1,2,4-triazol-5-yl)-8 , 9-dihydro -2 H - pyrido [4,3,2- de] phthalazine -3 (7 H) - and a pharmaceutical composition comprising an on-tosylate salt, treating a disease or condition, such as cancer, To (8 S ,9 R )-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1 H -1,2,4-triazol-5-yl)-8, 9-dihydro-2 H -pyrido[4,3,2- de ]phthalazine-3(7 H )-one tosylate salt is provided.
展开▼
机译:本发明,包括结晶形式,(8℃,9,r r℃)-5-氟-8-(4-氟苯基)-9-(1-甲基 - 1 H i> -1,2,4-三唑-5-y1) -8,9-二氢-2h i> - 吡啶[4,3,2- De i>]酞菁-3(7℃/ h) - 酮盐盐形式,以及其制备方法。做。此外,(8℃/ s)-5-氟-8-(4-氟苯基)-9-(1-甲基-1, 1氟-8)-5-氟-8-(4-氟苯基)-9-(1-甲基-1, 1。 i> -1,2,4-三唑-5- y1)-8,9-二氢-2 h + - pyrido [4,3,2- de] i>酞嗪-3(7℃) - 和药物组合物,其包含甲苯甲磺酸盐盐,治疗疾病或病症,例如癌症,(8 S I>,9 r r℃-5-氟-8-(4-氟苯基)-9-(1-甲基-1 H i> -1,2,4-三唑-5-基) - 8,9-二氢-2 H磷嗪-3(7℃/酮)酞甲磺酸盐[4,3,2- ]酞菁提供盐。
展开▼